Wooridul Huebrain Limited

KSE 118000.KS

Wooridul Huebrain Limited Shareholders' Equity for the year ending December 31, 2023: USD 81.34 M

Wooridul Huebrain Limited Shareholders' Equity is USD 81.34 M for the year ending December 31, 2023, a 3.75% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Wooridul Huebrain Limited Shareholders' Equity for the year ending December 31, 2022 was USD 78.40 M, a -21.55% change year over year.
Wooridul Huebrain Limited Shareholders' Equity for the year ending December 31, 2021 was USD 99.94 M, a 43.17% change year over year.
Wooridul Huebrain Limited Shareholders' Equity for the year ending December 31, 2020 was USD 69.81 M, a 126.09% change year over year.
Wooridul Huebrain Limited Shareholders' Equity for the year ending December 31, 2019 was USD 30.88 M, a 87.79% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

KSE: 118000.KS

Wooridul Huebrain Limited

CEO	Ms. Soo-Kyung Kim
IPO Date	May 5, 2006
Location	South Korea
Headquarters	156, No. 202, Dream Building)
Employees	23
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Cosmetics Dental Care Hardware & Electronics Medical Instruments Personal Care Pharmaceuticals

Description

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014. Wooridul Huebrain Limited was founded in 2009 and is based in Seoul, South Korea.

Key trends

Past 5 years